Clinical Trial Update: MESA Treatment for NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is exploring the MESA treatment regimen for extranodal NK/T-cell lymphoma, with the current trial status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• MESA treatment regimen

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Lymphoma, Extranodal NK-T-Cell | Phase 2 | Status: UNKNOWN